Amelimojarad, M., Amelimojarad, M., Wang, J., & Pourmahdian, A. (2023). miR-382-5p promotes breast cancer invasion via the regulation of PTEN.
Cheng, J., Deng, H., Xiao, B., Zhou, H., Zhou, F., Shen, Z., & Guo, J. (2012). piR-823, a novel non-coding small RNA, demonstrates in vitro and in vivo tumor suppressive activity in human gastric cancer cells. Cancer Letters, 315(1), 12-17.
El Aamri, M., Zayani, R., Baachaoui, S., Mohammadi, H., Amine, A., & Raouafi, N. A Double–Amplified Fluorometric Genosensor for Sensitive Detection of PiRNA–651 as a Novel Biomarker of Cancer. Available at SSRN 4511716.
Gong, Z., Wang, J., Wang, D., Buas, M. F., Ren, X., Freudenheim, J. L., Belinsky, S. A., Liu, S., Ambrosone, C. B., & Higgins, M. J. (2019). Differences in microRNA expression in breast cancer between women of African and European ancestry. Carcinogenesis, 40(1), 61-69.
Li, H., Li, L., Qiu, X., Zhang, J., & Hua, Z. (2023). The interaction of CFLAR with p130Cas promotes cell migration. Biochimica et Biophysica Acta (BBA)-Molecular Cell Research, 1870(2), 119390.
Limanówka, P., Ochman, B., & Świętochowska, E. (2023). PiRNA Obtained through Liquid Biopsy as a Possible Cancer Biomarker. Diagnostics, 13(11), 1895.
ME, J. F., Siegel, R. L., Isabelle Soerjomataram, M., & Ahmedin Jemal, D. (2024). Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
Najafi, H., Naseri, M., Zahiri, J., Totonchi, M., & Sadeghizadeh, M. (2019). Identification of the molecular events involved in the development of prefrontal cortex through the analysis of RNA-seq data from BrainSpan. ASN neuro, 11, 1759091419854627.
Roy, J., Sarkar, A., Parida, S., Ghosh, Z., & Mallick, B. (2017). Small RNA sequencing revealed dysregulated piRNAs in Alzheimer's disease and their probable role in pathogenesis. Molecular BioSystems, 13(3), 565-576.
Rui, T., Wang, K., Xiang, A., Guo, J., Tang, N., Jin, X., Lin, Y., Liu, J., & Zhang, X. (2023). Serum exosome-derived piRNAs could Be promising biomarkers for HCC diagnosis. International Journal of Nanomedicine, 1989-2001.
Tan, L., Mai, D., Zhang, B., Jiang, X., Zhang, J., Bai, R., Ye, Y., Li, M., Pan, L., & Su, J. (2019). PIWI-interacting RNA-36712 restrains breast cancer progression and chemoresistance by interaction with SEPW1 pseudogene SEPW1P RNA. Molecular cancer, 18, 1-15.
Tsachaki, M., Strauss, P., Dunkel, A., Navrátilová, H., Mladenovic, N., & Odermatt, A. (2020). Impact of 17β-HSD12, the 3-ketoacyl-CoA reductase of long-chain fatty acid synthesis, on breast cancer cell proliferation and migration. Cellular and Molecular Life Sciences, 77, 1153-1175.
Vychytilova-Faltejskova, P., Stitkovcova, K., Radova, L., Sachlova, M., Kosarova, Z., Slaba, K., Kala, Z., Svoboda, M., Kiss, I., & Vyzula, R. (2018). Circulating PIWI-interacting RNAs piR-5937 and piR-28876 are promising diagnostic biomarkers of colon cancer. Cancer Epidemiology, Biomarkers & Prevention, 27(9), 1019-1028.
Wu, X., Pan, Y., Fang, Y., Zhang, J., Xie, M., Yang, F., Yu, T., Ma, P., Li, W., & Shu, Y. (2020). The biogenesis and functions of piRNAs in human diseases. Molecular Therapy-Nucleic Acids, 21, 108-120.
Zhang, H., & Li, Y. (2024). Potential roles of PIWI-interacting RNAs in breast cancer, a new therapeutic strategy. Pathology-Research and Practice, 155318.
Zhang, L., Meng, X., Li, D., & Han, X. (2020). piR-001773 and piR-017184 promote prostate cancer progression by interacting with PCDH9. Cellular Signalling, 76, 109780.
Zhou, J., Xie, H., Liu, J., Huang, R., Xiang, Y., Tian, D., & Bian, E. (2023). PIWI-interacting RNAs: critical roles and therapeutic targets in cancer. Cancer Letters, 216189.